🔎 Trials Near Me

Gara Jalqabaatti › Obesity › California

Qorannoo klinikaalii Obesity California keessatti

Qorannoo 99 Obesity f California keessatti hirmaatuu jiru.

Magaalota California keessatti

Takkalaa qorannoo (Ingiliffa)

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Ark Clinical Research- Tustin, Fountain Valley
  • Long Beach Clinical Trials Services Inc, Long Beach
  • Ark Clinical Research- Long Beach, Long Beach
  • fi 6 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • San Fernando Valley Health Institute, Canoga Park
  • Core Healthcare Group, Cerritos
  • Velocity Clinical Research Chula Vista, La Mesa
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684144

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Valley Clinical Trials, LLC dba Flourish Research, Covina
  • Velocity Clinical Research- Huntington Park, Huntington Park
  • Orange County Research Center, Lake Forest
  • fi 5 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433

Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity

  • San Diego State University, San Diego
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05726942

Efficacy of Using Mobile Health Applications for Health

  • San Diego State University, San Diego
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05589155

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • John Muir Health - Concord /ID# 282469, Concord
  • NorCal Medical Research /ID# 283117, Greenbrae
  • Velocity Clinical Research - Huntington Park /ID# 282987, Huntington Park
  • fi 6 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07752979

Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population

  • San Diego State University, San Diego
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05279729

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects

  • ProSciento, INC, Chula Vista
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07675590

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

  • Cedars Sinai Medical Center, Los Angeles
Namoota walitti qabaa jira
Umuriin 21 hanga 65 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07090005

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • Neighborhood Healthcare, Escondido
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 8 hanga 18 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07253285

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Thrive Clinical Research Group, Glendora
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07783802

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  • Torrance Clinical Research Institute, Inc., Lomita
  • Diablo Clinical Research, Inc., Walnut Creek
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

  • Diablo Clinical Research - Flourish Research, Walnut Creek
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07685808

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • San Fernando Valley Health Institute, Canoga Park
  • Headlands Research California, LLC, Escondido
  • ImmuniMet, LLC, Modesto
  • fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07595549

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  • Profound Research, Oceanside
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07837973

Stanford Healthy Goals Study

  • Stanford University, Stanford
Namoota walitti qabaa jira
Umuriin 10 hanga 15 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07839832

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  • First Valley Medical Group, Lancaster
  • Desert Oasis Healthcare, Palm Springs
  • Western University of Health Sciences, Pomona
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07668414

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Providence Medical Foundation, Fullerton
  • Torrance Clinical Research Institute, Inc., Lomita
  • Diablo Clinical Research, Inc., Walnut Creek
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07720271

Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

  • Parexel International, Glendale
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07594093

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  • Research Site, Escondido
  • Research Site, Lincoln
  • Research Site, Walnut Creek
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07776509

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Smart Cures Clinical Research, Anaheim
  • Cedars-Sinai Medical Center, Beverly Hills
  • United Medical Doctors - Los Alamitos, Los Alamitos
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Loma Linda University School of Medicine, Loma Linda
  • Childrens Hospital of Los Angeles, Los Angeles
  • UCLA Mattel Children's Hospital, Los Angeles
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Smart Cures Clinical Research, Anaheim
  • Cedars-Sinai Medical Center, Beverly Hills
  • United Medical Doctors - Los Alamitos, Los Alamitos
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937086

A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity

  • Orange County Research Center, Lake Forest
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07731139

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Irvine Clinical Research, Irvine
  • Scripps Whittier Diabetes Institute, La Jolla
  • EndoTrials Center for Clinical Research, La Mesa
  • fi 5 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • San Fernando Valley Health Institute, Canoga Park
  • AMCR Institute, Escondido
  • NorCal Medical Research, Inc, Greenbrae
  • fi 6 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07282600

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • Ark Clinical Research - Fountain Valley, Fountain Valley
  • Wolverine Clinical Trials, Santa Ana
  • Encompass Clinical Research, Spring Valley
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • NorCal Medical Research, Inc, Greenbrae
  • Velocity Clinical Research, Huntington Park, Huntington Park
  • Peninsula Research Associates, Rolling Hills Estates
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • Ark Clinical Research, Long Beach
  • Collaborative Neuroscience Research, LLC, Los Alamitos
  • Artemis Institute for Clinical Research, Riverside
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07369011

CHOICE to AVOID or RESIST

  • Cedars-Sinai Medical Center, Beverly Hills
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06521021

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • Neighborhood Healthcare Institute of Health, Escondido
  • Ark Clinical Research - Fountain Valley, Fountain Valley
  • Desert Oasis Healthcare Medical Group, Palm Springs
  • fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Bakersfield
  • Research Site, Gardena
  • Research Site, Lincoln
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07784270

A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

  • Research Site, Glendale
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07723833

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Banning
  • AURORA-2 Clinical Site, Chula Vista
  • AURORA-2 Clinical Site, Covina
  • fi 6 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • National Heart Institute, Beverly Hills
  • Valley Clinical Trials, LLC dba Flourish Research, Covina
  • National Institute of Clinical Research, Huntington Beach
  • fi 9 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07037459

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Banning
  • AURORA-1 Clinical Site, Chula Vista
  • AURORA-1 Clinical Site, Covina
  • fi 5 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743463

An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being

  • San Diego State University, San Diego
  • UC San Diego Health, San Diego
Namoota walitti qabaa jira
Umuriin 18 fi ol · Dubartoota · Haaromfame 15-Ful-2026 · NCT07792837

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Orange County Research Center, Lake Forest
  • Ark Clinical Research, Long Beach
  • Catalina Research Institute, LLC, Montclair
  • fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Wolverine Clinical Trials, Santa Ana
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06897475

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.